Updates are available Correction dated 2021-03-10
Click to view Correction: https://doi.org/10.1007/s00134-021-06379-1
-
Authors
Buetti, Niccolò
Ruckly, Stéphane
de Montmollin, Etienne
Reignier, Jean
Terzi, Nicolas
Cohen, Yves
Siami, Shidasp
Dupuis, Claire
Timsit, Jean-François https://orcid.org/0000-0002-6063-7383
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P400PM_183865)
Gottfried und Julia Bangerter-Rhyner-Stiftung
- License Information
-
More Information
Article History
Received: 27 October 2020
Accepted: 2 January 2021
First Online: 27 January 2021
Change Date: 10 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00134-021-06379-1
Compliance with ethical standards
:
: The authors have disclosed that they do not have conflict of interest. NT reports fees from Pfizer outside the submitted work. JFT reports, outside the submitted work, participations to advisory boards for Pfizer, MSD, Nabriva, Medimune, Gilead, Becton–Dickinson, and lecture fees from MSD, Pfizer, Biomerieux.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The studies were approved by the regional ethic committees of Clermont-Ferrand.
: Informed consent was not required because the study did not modify patients' management and the data were anonymously collected.
: Not applicable.
Free to read: This content has been made available to all.
